Subsequent Events	3 Months Ended
Mar. 31, 2026
Subsequent Events
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date through May 14, 2026. Based on this review, management identified the following subsequent events that are required disclosures in the unaudited condensed financial statements. On April 20, 2026, the Company held an extraordinary general meeting in lieu of an annual meeting of shareholders (the “2026 Shareholder Meeting”), where the shareholders of the Company approved certain proposals, including, among others, the proposals to amend Articles 48.7 and 48.8 of the Company’s amended and restated memorandum and articles of association to provide that the Company must (i) consummate a business combination, or (ii) cease its operations except for the purpose of winding up if it fails to complete such business combination and redeem or repurchase 100% of the Company’s public shares included as part of the public units issued in the Company’s initial public offering, by June 12, 2027, without the need for any further approval of the Company’s shareholders. Further, at the 2026 Shareholder Meeting, the shareholders of the Company also approved, among other things, that the Trustee must commence liquidation of the Trust Account by June 12, 2027. Upon the shareholders’ approval, on April 20, 2026, the Company and the Trustee entered into an amendment to the Trust Agreement accordingly. In connection with the 2026 Shareholder Meeting, on April 21, 2026, 34,818 Ordinary Shares of the Company were rendered for redemption, and $444,170 was released from the Trust Account to pay such redeeming shareholders on April 21, 2026. As a result, as of the date hereto, the Company has 2,369,416 Ordinary Shares issued and outstanding, including 58,666 public shares.

Subsequent Events

3 Months Ended

Mar. 31, 2026

Note 10 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through May 14, 2026. Based on this review, management identified the following subsequent events that are required disclosures in the unaudited condensed financial statements.

On April 20, 2026, the Company held an extraordinary general meeting in lieu of an annual meeting of shareholders (the “2026 Shareholder Meeting”), where the shareholders of the Company approved certain proposals, including, among others, the proposals to amend Articles 48.7 and 48.8 of the Company’s amended and restated memorandum and articles of association to provide that the Company must (i) consummate a business combination, or (ii) cease its operations except for the purpose of winding up if it fails to complete such business combination and redeem or repurchase 100% of the Company’s public shares included as part of the public units issued in the Company’s initial public offering, by June 12, 2027, without the need for any further approval of the Company’s shareholders. Further, at the 2026 Shareholder Meeting, the shareholders of the Company also approved, among other things, that the Trustee must commence liquidation of the Trust Account by June 12, 2027. Upon the shareholders’ approval, on April 20, 2026, the Company and the Trustee entered into an amendment to the Trust Agreement accordingly.

In connection with the 2026 Shareholder Meeting, on April 21, 2026, 34,818 Ordinary Shares of the Company were rendered for redemption, and $444,170 was released from the Trust Account to pay such redeeming shareholders on April 21, 2026. As a result, as of the date hereto, the Company has 2,369,416 Ordinary Shares issued and outstanding, including 58,666 public shares.